Position in CGEM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$177,207,719
+$68,525,831 QoQ
Shares Held
9,731,341
+27.2% QoQ
Ownership
15.1%
of shares outstanding
% of Portfolio
10.81%
of 13F equity value
Holder Rank
#1
of 182 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CGEM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MPM BIOIMPACT LLC holds $1,463,416,616 across 34 Biotechnology names. CGEM ranks #1 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGEM |
Cullinan Therapeutics, Inc.
This page
|
9,731,341 | $177,207,719 | |
| 2 | AKTS |
Aktis Oncology, Inc.
|
4,835,872 | $155,860,154 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
492,483 | $92,232,216 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
771,028 | $67,040,884 | |
| 5 | EWTX |
Edgewise Therapeutics, Inc.
|
1,620,780 | $65,852,291 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,122,731 | $63,782,348 | |
| 7 | DBVT |
DBV Technologies S.A.
|
3,666,284 | $60,127,057 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
3,073,577 | $57,322,211 |
All Filings in CGEM
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $177,207,719 | 9,731,341 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $108,681,888 | 7,648,268 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $79,159,573 | 7,648,268 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $45,354,229 | 7,648,268 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $57,591,458 | 7,648,268 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $57,897,388 | 7,648,268 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $93,155,904 | 7,648,268 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $128,032,006 | 7,648,268 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $133,385,793 | 7,648,268 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $130,326,486 | 7,648,268 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $77,935,850 | 7,648,268 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $69,216,825 | 7,648,268 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $82,295,363 | 7,648,268 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $78,241,781 | 7,648,268 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $80,689,227 | 7,648,268 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $98,050,795 | 7,648,268 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $98,050,795 | 7,648,268 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $80,077,365 | 7,648,268 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $118,012,775 | 7,648,268 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $172,621,408 | 7,648,268 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $203,782,590 | 7,913,887 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $329,771,671 | 7,913,887 | Shares | Sole | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||